What is Henry Schein?
Henry Schein, Inc. is a global provider of health care products and services, catering to dental practitioners, laboratories, physician practices, and various institutional health care clinics. The company operates across two primary segments: Health Care Distribution, which encompasses a wide array of dental and medical supplies from infection-control products to pharmaceuticals and diagnostic tools; and Technology and Value-Added Services, offering practice management software, financial services, and network solutions. Founded in 1932 and headquartered in Melville, New York, Henry Schein has built a comprehensive portfolio to support health care providers worldwide.
How much funding has Henry Schein raised?
Henry Schein has raised a total of $322.8M across 3 funding rounds:
Stock Offering
$72.8M
Debt
$12K
Other Financing Round
$250M
Stock Issuance/Offering (1995): $72.8M, investors not publicly disclosed
Debt (2024): $12K led by Central Pacific Bank
Other Financing Round (2025): $250M supported by KKR
Key Investors in Henry Schein
KKR
KKR is a global investment firm focused on private markets, aiming to fortify companies and communities. Their involvement suggests a strategic partnership for growth and operational enhancement.
Central Pacific Bank
Central Pacific Bank provided debt financing, indicating a traditional financial backing for operational needs or specific projects.
What's next for Henry Schein?
The recent major strategic investment indicates Henry Schein's focus on expanding its technological capabilities and value-added services. This capital is likely to fuel further integration of digital solutions into health care practices, enhancing operational efficiency and patient care. The company's long history and broad market reach suggest a strategy aimed at consolidating its leadership position through technological innovation and strategic partnerships, positioning it for continued enterprise-level growth.
See full Henry Schein company page
